These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of Guillain-Barré syndrome]. Zagar M Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018 [TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II. Hartung HP; Pollard JD; Harvey GK; Toyka KV Muscle Nerve; 1995 Feb; 18(2):154-64. PubMed ID: 7823973 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and therapy of polyradiculoneuritis of the Landry-Guillain-Barré syndrome type]. Stefan H Anasth Intensivther Notfallmed; 1987 Dec; 22(6):287-90. PubMed ID: 3439591 [TBL] [Abstract][Full Text] [Related]
12. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome]. Lüke C; Dohmen C; Dietlein TS; Brunner R; Lüke M; Krieglstein GK Klin Monbl Augenheilkd; 2007 Dec; 224(12):932-4. PubMed ID: 18260057 [TBL] [Abstract][Full Text] [Related]
13. The Guillain-Barré syndrome: diagnosis, treatment and prognosis. van der Meché FG Acta Neurol Belg; 1994; 94(2):124-7. PubMed ID: 8036879 [TBL] [Abstract][Full Text] [Related]
14. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases]. Uldry PA; Bogousslavsky J; Regli F Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066 [TBL] [Abstract][Full Text] [Related]
15. Second response to immunoglobulin in recurrent Guillain-Barré syndrome. Nagappan R; Barker J N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925 [TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]